Physician profile
Jerry D Champ
NPI 1881670941
$8,739.43
in general payments reported to CMS, 2019-2025
39 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $677 · 2021: $1,392 · 2022: $1,386 · 2023: $1,462 · 2024: $1,562 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,080.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,215.29 | 2019-2025 | |
| Inari Medical, INC. | $997.86 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $695.49 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $644.04 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $608.63 | 2019-2025 | Watchman Flx, Bodyguardian, Watchman |
| Abbott Laboratories | $608.30 | 2019-2025 | Cardiomems, Mitraclip, Pressurewire |
| Pfizer INC. | $484.21 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $462.11 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $363.62 | 2019-2025 | Farxiga |
| Amgen INC. | $333.65 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $317.44 | 2021-2025 | Verquvo, Capvaxive |
| Abiomed | $274.54 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.12 | 2019-2023 | Jardiance |
| Amarin Pharma, INC. | $159.46 | 2020-2022 | |
| Astellas Pharma US INC | $136.26 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $123.44 | 2024-2025 | (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Alnylam Pharmaceuticals INC. | $105.86 | 2021-2024 | Onpattro |
| Medtronic, INC. | $105.45 | 2021-2025 | Corevalve Evolut R |
| Novo Nordisk INC | $102.92 | 2024-2025 | Wegovy |
| Cook Medical LLC | $98.11 | 2023-2025 | Zilver Ptx, Advance, Cook Celect |
| Bayer Healthcare Pharmaceuticals INC. | $90.96 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $76.80 | 2019 | |
| Stryker Corporation | $73.35 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kowa Pharmaceuticals America, INC. | $66.27 | 2020-2021 | |
| Shockwave Medical, INC | $60.24 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $53.38 | 2019-2024 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $45.14 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $37.28 | 2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $32.20 | 2022 | |
| Vital Connect, INC | $26.13 | 2025 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $23.94 | 2023 | Opsumit, Uptravi |
| Arbor Pharmaceuticals, INC. | $23.92 | 2019 | |
| Impulse Dynamics (USA) INC. | $17.22 | 2022 | |
| Bard Peripheral Vascular, INC. | $16.95 | 2024 | Rotarexs 6 F X 135 Cm |
| Medicomp INC | $15.64 | 2023 | Telepatch Cardiac Monitor |
| Cardiva Medical, INC. | $15.64 | 2022 | |
| Esperion Therapeutics, INC. | $15.12 | 2022 | |
| Biotronik INC. | $14.18 | 2022 | |
| Medtronic Vascular, INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Champ listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.